Home -> Law Blog Directory -> Public Defense Blogs -> Kansas Defenders
(866) 635-2689 for Personal Injury or (866) 635-9402 for Criminal Defense
Find a Local Lawyer
Divorce (866) 635-6190
Personal Injury (866) 635-2689
Criminal Defense (866) 635-9402
Public Defense
: Kansas DefendersPetitions for Review granted January 2010
Albright v. State, No. 102,454 (Kan. App. June 25, 2009)(unpublished)
Issue presented:
- Improper dismissal of appeal
State v. Huerta, No. 101,438 (Kan. App. May 21, 2009)(unpublished)
Issue presented:
- Improper dismissal of appeal
State v. Freeman, No. 100,792 (Kan. App. April 24, 2009)(unpublished)
Issue presented:
- Improper denial of motion to withdraw plea
Holmes v. State, No. 100,666 (Kan. App. Aug. 14, 2009)(unpublished)
Issue presented:
- Improper summary denial of K.S.A. 60-1507 motion alleging IAC
State v. Roberts, No. 100,233 (Kan. App. March 13, 2009)(unpublished)
Issue presented:
- Whether pretrial dismissal constitutes acquitttal under statute
State v. Berreth, No. 99,937 (Kan. App. May 15, 2009)(unpublished)
Issue presented:
- Whether Court of Appeals had jurisdiction in previous appeal resulting in resentencing
State v. Johnson, No. 98,812 (Kan. App. April 3, 2009)(unpublished)
Issue presented:
- Improper denial of motion to suppress evidence and statements
State v. Simmons, No. 98,770 (Kan. App. April 10, 2009)(unpublished)
Issue presented:
- Prosecutorial misconduct
State v. Long, No. 98,736 (Kan. App. May 20, 2009)
Remanded for reconsideration in light of State v. Youngblood (prohibitng use of misdemeanor for enhancement if violation of right to counsel)
Full post as published by Kansas Defenders on January 10, 2010 (boomark / email).
FDA Issues Update on Safety Review Orlistat
Orlistat FDA Issues Update on Safety Review
Aurora Loan Faces Class Action over Mortgage Review Services
Aurora Loan Faces Class Action over Mortgage Review Services
FDA Review of Prostate Cancer Treatment Prompts Warning of Risk for Diabetes
Prostate Cancer Treatment FDA Review Prompts Warning of Risk for Diabetes
Xigris
Study Prompts FDA Safety Review
Lipitor
Review of Studies Show No Significant Benefit in Women
Wrinkle-Fillers
FDA to Review Labeling due to Adverse Event Reports

Petitions to Watch | Conference of 1.8.10
Petitions to Watch | Conference of 1.9.09
Petitions to Watch | Conference of 1.15.10
Petitions to Watch | Conference of 1.22.10
Petitions to Watch | Conference of 1.16.09
Petitions to Watch | Conference of 1.23.09








